Alnylam Pharma joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine: San Diego Saturday, September 20, 2025, 12:00 Hrs [IST ...

Members leverage AI-powered dataset to accelerate pharma R&D, and ensure that disease-impacting discoveries benefit all ...

Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease . Following early ...

Illumina, Inc., a publicly-traded biotechnology company, agreed to a $9.8 million settlement with the U.S. Department of Justice (DOJ) in response to alleged violations of the False Claims Act (FCA).

SAN DIEGO, Sept. 3, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS ...

The global Molecular Diagnostics Market, valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is ...

The global Molecular Diagnostics Market, valued at US$18.29 billion in 2024, stood at US$19.48 billion in 2025 and is projected to advance at ...

Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto™ platform to ...

Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto platform to streamline sample preparation across ...

Illumina Inc. closed 39.28% short of its 52-week high of $156.66, which the company reached on November 5th.

Shares of Illumina Inc. ILMN shed 1.79% to $96.07 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.51% to 6,448.26 and the ...

By the third quarter of 2025, the Department of Justice (DOJ) has made plain that it will continue using the False Claims Act (FCA) to ...